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background: Subtle ST-segment elevation (STE) represents a challenge in STEMI diagnosis. Our aim was to compare clinical characteristics and 
outcomes of STEMI patients (pts) according to the degree of STE.
methods: We conducted a prospective study in a tertiary care hospital. Study population comprised all consecutive pts with suspected STEMI 
admitted for primary PCI. Pts were divided in groups of subtle STE (STE of 0 to 1 mm) or marked STE (STE>1mm). STE was measured in the lead with 
maximal elevation above the PR-segment. Primary end point was the composite of death or recurrent infarction at follow-up.
results: 447 pts were included, 82 (18.3%) of whom presented with subtle STE. Mean follow-up was 19.0±4.9 months. Baseline characteristics are 
shown in the table. Subtle STE group showed higher prevalence of prior coronary artery disease, multi vessel disease and left circumflex involvement, 
and a trend towards larger system delays. Marked STE group presented with larger infarcts and had a higher incidence of heart failure. The rates of 
primary end point did not differ significantly between groups, neither in univariate analysis (10.0% vs. 12.6%, p=0.514), nor after adjustment in a 
multivariate analysis (p=0.955).
Conclusions: Almost one in five patients with STEMI presents with subtle ST-elevation. These pts have more complex coronary disease, and their 
prognosis does not differ from those with marked STE. Early recognition of subtle STE is of paramount importance to provide adequate treatment.
Marked STE (n=365) Subtle STE (n=82) p-value
Age (yrs) 64 (53-76) 62 (52-73) 0.210
Gender (male) 74% (269) 78% (64) 0.414
Diabetes 17% (61) 24% (20) 0.103
Chronic kidney disease 8% (29) 14% (11) 0.098
Prior CAD 10% (35) 21% (17) 0.004
Anterior location 38% (140) 20% (16) 0.001
Symptoms duration (min) 125 (79-211) 161 (67-307) 0.260
Door-to-balloon time (min) 84 (62-110) 90 (60-139) 0.075
Infarct related artery (LCX) 13% (46) 36% (25) <0.001
IRA diameter ≥3.0 mm 74% (239) 71% (45) 0.701
Multi vessel disease 44% (159) 57% (47) 0.025
Initial TIMI 0-1 flow 87% (309) 86% (65) 0.679
LVEF at presentation 60 (49-68) 60 (49-70) 0.441
Maximum Killip class III-IV 18% (64) 9% (7) 0.036
Peak Troponin I 65 (30-123) 25 (12-65) <0.001
Peak CK 2121 (1159-3304) 1008 (530-1910) <0.001
